Early-stage
Phagenesis expands series-B round to $17m
Phagenisis has extended its series-B funding round to reach $17m.
HealthCap, Industrifonden et al. back Oncopeptides
HealthCap, Industrifonden and other investors have taken part in a series-A financing round for Swedish medical start-up Oncopeptides AB.
Mig et al. add €9.5m to SuppreMol series-D round
Mig AG and BioMed Partners have injected an additional €9.5m into Germany-based SuppreMol alongside a number of other backers in an extension of the company’s series-D funding round.
Idinvest backs Forsee Power Solutions
Idinvest Partners has provided growth capital to rechargeable industry-grade battery specialist Forsee Power Solutions.
Swedish venture faces critical funding gap
When it comes to venture capital, opportunities abound in Sweden. Yet, despite the success stories, a critical funding gap threatens the future of the industry. Amy King reports
Iris and Elaia invest €1.3m in Adomik
Iris Capital and Elaia Partners have injected €1.3m in a series-A funding round for Paris-based ad-exchange adviser and analysis platform provider Adomik.
Earlybird Venture et al. invest $2.8m in Versus IO
Earlybird Venture Capital, 500 Startups, High-Tech Gründerfonds (HTGF) and two angel investors have backed product comparison platform Versus IO in a $2.8m series-A funding round.
Growth capital dealflow ebbs in Q1
Emphasising the pervasive nature of the activity decline in the first quarter of 2013, deal volume in the expansion category recorded a drop commensurate with that of the buyout market.
Caixa Capital Risc leads €1.1m round for iMicroQ
Caixa Capital Risc has led a €1.1m funding round for Spanish biotech firm iMicroQ.
Cardio3 raises €19m in new funding round
Belgian biopharmaceutical company Cardio3 Biosciences has completed a funding round that saw previous investors inject €7m in new equity alongside the conversion of €12m in existing convertible loans.
Investment AB Kinnevik et al. invest $20m in Foodpanda
Investment AB Kinnevik and Phenomen Ventures have led a funding round in excess of $20m for Foodpanda, a global food delivery service.
FTBPro raises $5.8m from VC duo
Battery Ventures and Gemini Israel Ventures have provided $5.8m to FTBPro, a fan-generated football content platform based in London.
Kurma leads €17m series-B round for Stat Diagnostica
Kurma Life Sciences Partners has led a €17m series-B round for Spanish medical diagnostics company Stat Diagnostica.
Novartis Venture et al. in €33m series-C round for Opsona
A consortium of new and existing investors has injected €33m into Irish immunology drug development company Opsona Therapeutics as part of a series-C funding round.
Wellington invests €4m in €18.2m Genticel series-C
Wellington Partners has injected €4m into French vaccine developer Genticel as part of an €18.2m series-C funding round alongside existing shareholders.
Seventure Partners invests €2.5m in Personal MedSystems
Seventure Partners has invested in German mobile medical equipment company Personal MedSystems, alongside High-Tech Gründerfonds, as part of a €2.5m series-A financing.
Q1 activity hits five-year low
The UK & Ireland’s first-quarter activity levels are at their lowest level for five years, according to the latest research from unquote” data.
EdRip and Forbion lead funding for Allecra Therapeutics
Edmond de Rothschild Investment Partners (EdRip) and Forbion Capital Partners have invested in a €15m series-A round for Swiss biotech company Allecra Therapeutics.
HTGF et al. invest €2.6m in Rodos BioTarget
High-Tech Gründerfonds (HTGF), InvestImpuls-Fonds and KfW’s ERP Start Fund have invested €2.6m of growth capital in German biotech company Rodos BioTarget, alongside private investors and family offices.
360 Capital Partners and Eataly launch Eataly Net
360 Capital Partners has teamed up with Italian food retailer Eataly to found Eataly's online business Eataly Net.
UK Watch: Q1 activity hits five-year low
UK private equity saw its worst quarter since 2009 despite widespread optimism in the market, according to the latest unquote” UK Watch, in association with Corbett Keeling.
Boehringer Ingelheim invests in Eyevensys
Boehringer Ingelheim Venture Fund (BIVF) has invested in French biotech company Eyevensys, marking the start of a new funding round for the business.
Demeter and 123Venture back Cooltech Applications
Demeter Partners and 123Venture have joined existing investors in an €8m funding round for French magnetic refrigeration specialist Cooltech Applications.
Demeter et al. inject €7m into Ideol
Demeter Partners, Sofimac and Soridec have provided Ideol, a French developer of foundations for offshore wind farms, with €7m of funding.